October 29, 2013

Sanofi Pasteur Announces Vaccine Discovery Collaboration with the Bill & Melinda Gates Foundation

Accelerated development and more effective approaches to R&D expected

 

Sanofi Pasteur Announces Vaccine Discovery Collaboration with the Bill & Melinda Gates Foundation
Accelerated development and more effective approaches to R&D expected

Lyon, France and Rio de Janeiro, Brazil – October 29, 2013 – Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today a partnership with the Bill & Melinda Gates Foundation to explore and develop new platforms and methods intended to accelerate vaccine R&D, particularly in areas of global health. The announcement was made at the Grand Challenges in Global Health meeting in Rio de Janeiro, Brazil during a session focused on affordable technologies for the developing world. The conference initiated by the Gates Foundation was first held in 2003 to focus on persistent challenges in improving health and development in poor countries.